ANI Pharmaceuticals

ANI Pharmaceuticals

Yahoo Finance • last month

ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board

ANI Pharmaceuticals (NasdaqGM: ANIP) appointed biotechnology executive Henry Gosebruch to its Board of Directors. Gosebruch previously held leadership roles at Lakefront Biotherapeutics, Neumora Therapeutics, and AbbVie. Board member Muthu... Full story

Yahoo Finance • last month

2 Reasons to Like ANIP (and 1 Not So Much)

2 Reasons to Like ANIP (and 1 Not So Much) ANI Pharmaceuticals currently trades at $76.15 per share and has shown little upside over the past six months, posting a middling return of 3%. The stock also fell short of the S&P 500's 11.7% ga... Full story

Yahoo Finance • 2 months ago

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sec... Full story

Yahoo Finance • 2 months ago

ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results

Quarterly net revenues of $266.0 million, an increase of 25.9% year-over-yearPurified Cortrophin® Gel net revenues of $117.1 million, an increase of 43.5% year-over-yearQuarterly GAAP net income available to common shareholders of $24.7 mi... Full story

Yahoo Finance • 2 months ago

1 Healthcare Stock Worth Your Attention and 2 We Question

1 Healthcare Stock Worth Your Attention and 2 We Question From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong fina... Full story

Yahoo Finance • 3 months ago

2 Reasons to Watch ANIP and 1 to Stay Cautious

2 Reasons to Watch ANIP and 1 to Stay Cautious Since January 2026, ANI Pharmaceuticals has been in a holding pattern, posting a small loss of 3.5% while floating around $78.49. The stock also fell short of the S&P 500's 7.9% gain during t... Full story

Yahoo Finance • 3 months ago

1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare st... Full story

Yahoo Finance • 3 months ago

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

PRINCETON, N.J., July 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its second quarter 2026 financial results on Friday, August 7, 2026, at 8:00 a... Full story

Yahoo Finance • 3 months ago

2 Small-Cap Stocks Worth Investigating and 1 We Brush Off

2 Small-Cap Stocks Worth Investigating and 1 We Brush Off Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have i... Full story

Yahoo Finance • 3 months ago

ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge

Key Points An ANI Pharmaceuticals executive reported selling 2,850 shares directly for about $240,000 on June 29, 2026. The sale represented 1.58% of Carey's direct holdings, reducing his direct stake to 177,543 shares post-transaction. A... Full story

Yahoo Finance • 3 months ago

3 of Wall Street’s Favorite Stocks to Target This Week

3 of Wall Street's Favorite Stocks to Target This Week Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it's worth remembering that analysts rarely i... Full story

Yahoo Finance • 4 months ago

Ani (ANIP) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Friday, May 8, 2026, 8 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Nikhil Lalwani Senior Vice President and Chief Financial Officer — Stephen Carey Senior Vice President and Hea... Full story

Yahoo Finance • 4 months ago

Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Amneal (NASDAQ:AMRX) and the best and worst performers in the generic pharmaceutic... Full story

Yahoo Finance • 4 months ago

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Globa... Full story

Yahoo Finance • 5 months ago

ANI Pharmaceuticals Refocuses On Rare Disease As Buybacks And Insider Sales Rise

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. ANI Pharmaceuticals (NasdaqGM:ANIP) is sharpening its focus on specialty and rare disease products, including Cortrophin Gel and I... Full story

Yahoo Finance • 5 months ago

Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Jazz Pharmaceuticals (NASDAQ:JAZZ) and the best and worst performers in the pharma... Full story

Yahoo Finance • 6 months ago

ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

PRINCETON, N.J., April 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its first quarter 2026 financial results on Friday, May 8, 2026, prior to the... Full story

Yahoo Finance • 6 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

PRINCETON, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pimozide Tablets 1 mg and 2 mg. ANI’s Pimozide Tablets is the generic version of the referenc... Full story

Yahoo Finance • 6 months ago

1 Small-Cap Stock for Long-Term Investors and 2 We Turn Down

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it ha... Full story

Yahoo Finance • 6 months ago

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

PRINCETON, N.J., April 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Carbamazepine Extended-Release Capsules, 100 mg, 200 mg and 300 mg. ANI’s Carbamazepine Exten... Full story